All Things Chemical® Podcast

March 16, 2023
What is Product Stewardship’s Value to a Company? — A Conversation with Tina N. Armstrong, Ph.D.
This week, I sat down with Dr. Tina N. Armstrong, a Vice President with Arcadis U.S., Inc., to discuss the role of product stewardship in business organizations today. To those of us in this space, Tina is a rock star. In addition to her role as a business leader and scientist at Arcadis, Tina is a professor in product stewardship strategy and management at the Indiana University Richard M. Fairbanks School of Public Health, an author of many books and articles on product stewardship, and the 2022 awardee of the prestigious Allan K. Fleeger Distinguished Service Award conferred by the ... read more >
March 2, 2023
Product Stewardship, Supply Chain, and Downstream User Engagement — A Conversation with Catherine M. Croke, DBA
This week, I had the pleasure of catching up with Dr. Catherine M. Croke, B&C’s and our consulting affiliate’s, The Acta Group, new Director of Product Stewardship and Regulatory Affairs. Catherine joined us recently from Evonik Corporation, where she was Senior Advocacy and Compliance Manager. Catherine’s diverse and truly extraordinary background working for industrial chemical companies in a variety of science, business, and advocacy roles have made Catherine a core part of the B&C and Acta team. We discuss the expanding role and growing importance of product ... read more >
February 16, 2023
Health Canada’s Update to Rev 7/8 of GHS — A Conversation with Karin F. Baron
This week, I welcomed back to the studio Karin F. Baron, Director of Hazard Communication and International Registration Strategy at B&C and our consulting affiliate, The Acta Group. During this 100th All Things Chemical podcast, Karin and I discuss the very important recently released amendments to the Canadian Hazardous Products Regulations (HPR). The amendments are intended to align the HPR with the seventh revised edition (Rev 7) of the United Nations (UN) Globally Harmonized System of Classification and Labeling of Chemicals (GHS). No one on planet Earth knows the global state ... read more >
February 2, 2023
What to Expect on Capitol Hill and at EPA OCSPP in 2023 — A Conversation with Jim Aidala
This week, I sat down with Jim Aidala, Senior Government Affairs Consultant at B&C and its consulting affiliate, The Acta Group. We discuss what to expect in 2023 from Capitol Hill and the U.S. Environmental Protection Agency’s (EPA) Office of Chemical Safety and Pollution Prevention (OCSPP) when it comes to key chemical matters. Jim is, of course, one of the country’s most talented pesticide experts and, as a former Assistant Administrator of what is now OCSPP and a founding member of the Capitol Steps, offers laser-focused insights on chemicals with wit and flair. We cover a ... read more >
January 19, 2023
What to Expect in Chemicals Policy and Regulation in 2023 — A Conversation with Richard E. Engler, Ph.D.
Download transcript. This week, Dr. Richard E. Engler, Director of Chemistry for B&C and The Acta Group (Acta®), our consulting affiliate, returned to the studio to discuss what to expect in Toxic Substances Control Act (TSCA) regulation in the New Year. While we cannot predict with precision, we know 2023 will be a consequential year for several reasons: the first final risk management rule will be issued, the final per- and polyfluoroalkyl substance (PFAS) reporting rule will be issued, and the final Confidential Business Information rule will be issued -- and this is the ... read more >
January 5, 2023
EPA Adds Two New Chemical Categories: What It Means to Chemical Innovators — A Conversation with Richard E. Engler, Ph.D.
Download Transcript This week, Dr. Richard E. Engler, Director of Chemistry for B&C and The Acta Group, our consulting affiliate, returned to the studio to discuss the U.S. Environmental Protection Agency’s (EPA) bold moves in developing new chemical categories to help streamline the review of new chemicals under Toxic Substances Control Act (TSCA) Section 5. While the categorical approach to new chemical review is by no means new, it has stalled out in recent years, and EPA’s renewed work in this area is both timely and essential. Rich and I discuss the new category for ... read more >
December 8, 2022
TSCA Regulation of Articles: The Saga Continues — A Conversation with Richard E. Engler, Ph.D.
Download transcript. This week, Dr. Richard E. Engler, Director of Chemistry for B&C and The Acta Group, our consulting affiliate, returned to the studio to discuss the stubbornly vexatious problem of TSCA’s regulation of articles, a fancy name for products or finished goods. Most listeners to the podcast appreciate that this U.S. Environmental Protection Agency (EPA) Administration has specifically applied TSCA regulations to articles far more than in decades past. This policy pivot has caused a significant amount of commercial disruption and business uncertainty. This will ... read more >
November 10, 2022
Keeping up with CLP Changes — A Conversation with Karin F. Baron
Download transcript. This week, I welcomed back to the studio Karin F. Baron, Senior Regulatory Consultant at B&C and our consulting affiliate, The Acta Group. Karin and I discuss the controversial changes proposed by the European Commission to the regulation on classification, labeling, and packaging of substances and mixtures, better known as the CLP regulation. As our listeners know, no one knows this space better than Karin Baron. Karin explains why the proposed changes are likely to inject even greater dis-harmonization in the area of the global harmonization of packaging and ... read more >
October 27, 2022
Biotech’s Emergence in the EU and Globally — A Conversation with Dr. Claire Skentelbery
Download transcript. This week, I sat down with Dr. Claire Skentelbery, Director General, EuropaBio -- The European Association for Bioindustries. Many of you may know Claire from her prior role as Director General of the Nanotechnology Industries Association, where she energized that Brussels-based trade association to new and exciting heights. Claire has brought her considerable scientific, science policy, and trade association management skills to EuropaBio at an exciting time, as biotechnology is widely recognized to be a pivotal component of the European Union’s (EU) ... read more >
October 13, 2022
Misunderstood: The Excise Tax No One Likes or Understands — A Conversation with Douglas Charnas and Richard E. Engler, Ph.D.
Download transcript. This week I sat down with Doug Charnas, a nationally- recognized corporate and tax attorney and partner at McGlinchey, in its Washington, D.C. offices, and our own Dr. Richard Engler, Director of Chemistry at Bergeson & Campbell and at our consulting affiliate, The Acta Group. We discuss the recently reinstated Superfund Tax, which entities the tax applies to, what exactly is a taxable chemical and how to distinguish between taxable chemicals and taxable substances, and why just about everyone is really grumpy about this newly reinstated tax. ALL MATERIALS ... read more >
 1 2 3 >  Last › View 10 | 25 | 50 | 100 per page
 
BERGESON & CAMPBELL, P.C.
2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
202-557-3800 • 202-557-3836 (fax) | lawbc.com
Contact • Twitter
 
Privacy Policy | Terms of Use | Cookie Policy | Attorney Advertising | Trademarks
©2023 Bergeson & Campbell, P.C.
All Rights Reserved.

We are very pleased to offer complimentary subscription to our informative newsletter(s), but we will need to collect some information to do so.

Please carefully read the provisions of the PRIVACY POLICY and the TERMS OF SERVICE ( click to read )

When you opt-in by clicking the button below, you agree to share your USER ID, EMAIL ADDRESS, COMPANY AFFILIATION, and JOB TITLE for the purpose of receiving our emailed newsletter(s).

If you do not accept these terms of use, do not subscribe to our newsletter(s).




I agree to the collection and use of my personal data as described above.


I do not agree to the collection and use of my personal data as described above and therefore agree not to access this subscription form.